Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$2.2 - $4.01 $29,704 - $54,143
-13,502 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$3.38 - $5.71 $3,380 - $5,710
1,000 Added 8.0%
13,502 $52,000
Q1 2021

May 10, 2021

BUY
$3.77 - $6.05 $7,540 - $12,100
2,000 Added 19.04%
12,502 $67,000
Q4 2020

Jan 19, 2021

BUY
$3.12 - $4.08 $32,766 - $42,848
10,502 New
10,502 $39,000

About MediWound Ltd.


  • Ticker MDWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,735,200
  • Market Cap $690M
  • Description
  • MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...
More about MDWD
Track This Portfolio

Track Mission Wealth Management, LP Portfolio

Follow Mission Wealth Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mission Wealth Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Mission Wealth Management, LP with notifications on news.